Literature DB >> 10935493

Protein kinase A regulatory subunits in colon cancer.

C C Carlson1, S L Smithers, K A Yeh, L L Burnham, D T Dransfield.   

Abstract

The protein kinase A (PKA) is classified as type I or II depending on the association of the catalytic subunit with either the R(I) or R(II) regulatory subunits. Alterations in the levels of these regulatory subunits and PKA activity itself appear to affect cellular proliferation and tumorigenesis. We examined colorectal tumor specimens from 45 patients to investigate the potential role of cAMP-related signaling molecules in regulating tumorigenesis. Western blot analysis (PKA subunit protein levels) and in vitro kemptide phosphorylation assays (PKA catalytic subunit activity) were performed on human colorectal tumor tissue homogenates. R(I)beta protein levels were decreased 200% in ascending and 50% in descending colonic tumors compared to adjacent mucosa. R(II) protein levels were decreased 77% in descending colonic tumors but no change was observed in ascending colonic tumors compared to adjacent mucosa. PKA activity and the absolute amount of catalytic subunit protein in ascending and descending tumors were unchanged compared to adjacent mucosa. Differences in cAMP-related signaling molecules exist between neoplastic and normal colorectal tissues. These differences may not only serve as potential therapeutic targets for chemotherapeutic agents, but also lead to the identification of novel regulatory mechanisms involved in cellular proliferation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10935493      PMCID: PMC1508095          DOI: 10.1038/sj.neo.7900039

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  17 in total

1.  Requirement for cAMP-PKA pathway activation by M phase-promoting factor in the transition from mitosis to interphase.

Authors:  D Grieco; A Porcellini; E V Avvedimento; M E Gottesman
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728

2.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

3.  Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivo.

Authors:  Y S Cho-Chung
Journal:  J Cyclic Nucleotide Res       Date:  1980

4.  SOK2 may regulate cyclic AMP-dependent protein kinase-stimulated growth and pseudohyphal development by repressing transcription.

Authors:  M P Ward; C J Gimeno; G R Fink; S Garrett
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

5.  Protein kinase A phosphorylates cyclin D1 at three distinct sites within the cyclin box and at the C-terminus.

Authors:  A Sewing; R Müller
Journal:  Oncogene       Date:  1994-09       Impact factor: 9.867

Review 6.  The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases.

Authors:  Y S Cho-Chung; T Clair
Journal:  Pharmacol Ther       Date:  1993-11       Impact factor: 12.310

7.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

Authors:  C E Eberhart; R J Coffey; A Radhika; F M Giardiello; S Ferrenbach; R N DuBois
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

8.  Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells.

Authors:  D J Withers; H A Coppock; T Seufferlein; D M Smith; S R Bloom; E Rozengurt
Journal:  FEBS Lett       Date:  1996-01-02       Impact factor: 4.124

9.  An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.

Authors:  H Yokozaki; A Budillon; G Tortora; S Meissner; S L Beaucage; K Miki; Y S Cho-Chung
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 12.701

10.  Protein kinase A (PK-A) regulatory subunit expression in colorectal cancer and related mucosa.

Authors:  A W Bradbury; D C Carter; W R Miller; Y S Cho-Chung; T Clair
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

View more
  4 in total

1.  DHA induces apoptosis of human malignant breast cancer tissues by the TLR-4/PPAR-α pathways.

Authors:  Lijing Geng; Wei Zhou; Bing Liu; Xinyun Wang; Bo Chen
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

2.  Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).

Authors:  Una Kjällquist; Rikard Erlandsson; Nicholas P Tobin; Amjad Alkodsi; Ikram Ullah; Gustav Stålhammar; Eva Karlsson; Thomas Hatschek; Johan Hartman; Sten Linnarsson; Jonas Bergh
Journal:  BMC Cancer       Date:  2018-02-12       Impact factor: 4.430

3.  Low expression of A-kinase anchor protein 5 predicts poor prognosis in non-mucin producing stomach adenocarcinoma based on TCGA data.

Authors:  Zishao Zhong; Zhenhao Ye; Guihua He; Wang Zhang; Jing Wang; Suiping Huang
Journal:  Ann Transl Med       Date:  2020-02

4.  The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment.

Authors:  Alexandra M Fajardo; Gary A Piazza; Heather N Tinsley
Journal:  Cancers (Basel)       Date:  2014-02-26       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.